Venetoclax-Enhanced BUCY vs. Standard BUCY Conditioning in High-Risk AML and MDS Patients Undergoing Allo-HSCT (Ven-BUCY Study)
Abroad (travel likely)Recruiting
Conditions
Acute Myeloid Leukemia · High-Risk Acute Myeloid Leukemia · Myelodysplastic Syndromes · High-Risk Myelodysplastic Syndromes
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Study leads
Yanmin Zhao, MD
Principal Investigator
Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School Of Medicine